期刊文献+

MRI超短回波时间成像序列结合T2*映射技术用于在体耳软骨无创检测 被引量:1

Non-Invasive Measurement of Auricular Cartilage in vivo by UTE T2*Mapping
下载PDF
导出
摘要 提出使用磁共振图像(MRI)超短回波时间(UTE)成像序列结合T2*映射技术,对耳软骨T2*值进行在体无创检测,探究既能对耳软骨进行非侵入性成像又能定量评估在体耳软骨生物成分的方法,为耳软骨再造和修复整形手术评价的标准化提供新思路。首先,使用1个UTE和5个短回波时间(TE)的成像组合序列采集30名志愿者右侧外耳的MRI图像;然后,利用采集到的每名志愿者的图像进行组内刚性配准及手动分割耳软骨与外耳轮廓(包含耳软骨及周围组织,如皮肤、脂肪和其他软组织)的预处理;接下来,分别运用单指数和双指数衰减模型在分割出来的耳软骨和外耳区域进行T2*值测量;最后,分别使用这两种模型拟合耳软骨信号强度随回波时间变化的衰减曲线,并比较拟合模型的准确性。结果显示,在30例右耳的单成分分析(单指数模型)实验中,外耳的T2*m平均值为(49.269±16.979)ms,耳软骨的T2*m平均值为(23.799±9.629)ms。在双成分分析(双指数模型)中,外耳的短成分T2*s平均值为(11.713±3.111)ms,长成分T2*l平均值为(65.128±13.132)ms,耳软骨的短成分T2*s平均值为(5.577±1.830)ms,长成分T2*l平均值为(30.628±8.413)ms。统计分析显示,单成分分析计算得到的T2*m,和双成分分析计算得到的T2*s、T2*l,在外耳和耳软骨区域均存在显著差异(P<0.05)。在曲线拟合中,双指数模型优于单指数模型(R^2[bi]=0.999±0.001 vs R^2[mono]=0.905±0.014,P<0.05)。实验结果表明,超短回波时间成像序列结合T2*映射技术对在体耳软骨进行T2*值无创检测具备可行性,有望为软骨组织工程和3D生物打印技术制作的耳软骨-支架复合物应用在耳廓修复和再造中提供医学影像学的支撑,也为小耳畸形外科整形手术术后定量评估耳软骨提供一种可行性方案。 This paper proposed to utilize MRI ultra-short echo time(UTE)imaging in conjunction with T2*mapping for image-based analysis of in vivo auricular cartilage,exploring the technical feasibility of not only non-invasive imaging but also quantitative measurement of the biological components of auricular cartilage and providing innovative ideas for standardization and evaluation of advanced biotechnology-based microtia reconstruction and surgery.Firstly,in the presented method,30 volunteers were imaged for the right-sided ear using the sequence of multiple echo times(TE)containing one UTE and five short TEs.Secondly,these multiple images for each volunteer were preprocessed with intra-rigid registration and then manual segmentation of auricular cartilage and the external ear(containing not only auricular cartilage but also surrounding tissues,e.g.skin,fat,and other soft tissues).Next,for each volunteer,the component analysis was carried out to calculate the T2*values in ROIs of auricular cartilage and external ear respectively,using both the mono-and bi-exponential models(short component T2*and long component T2*).Finally,both exponential models were used to fit the curves of the auricular cartilage intensity versus echo time.In the experiment of monocomponent analysis of the 30 right-sided ears,the mean T2*value of external ear was(49.269±16.979)ms and the mean T2*value of segmented auricular cartilage was(23.799±9.629)ms.In the bi-component analysis,the mean short component T2*was(11.713±3.111)ms and the mean long component T2*was(65.128±13.132)ms for the external ear,while for the segmented auricular cartilage,the mean short component T2*was(5.577±1.830)ms and the mean long component T2*was(30.628±8.413)ms.There was a significant difference of T2*values calculated by both component analyses between the external ear and the auricular cartilage(P<0.05).The model with bi-exponential fitting outperformed the one with monoexponential fitting with a better fitted curve and a calculated value of R^2[bi]=0.999±0.001 vs R^2[mono]=0.905±0.014(P<0.05).Our preliminary results demonstrated that the proposed UTE T2*mapping has shown to be a feasible non-invasive means for quantifying the auricular cartilage in vivo and a potential tool used to image and evaluate the complex of auricular cartilage with biomaterials in reconstructive surgery for microtia using tissue engineering or 3D bioprinting technique in the future.
作者 李雪 张唯唯 Li Xue;Zhang Weiwei(State Key Laboratory of Medical Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100005,China)
出处 《中国生物医学工程学报》 CAS CSCD 北大核心 2020年第3期271-279,共9页 Chinese Journal of Biomedical Engineering
基金 中国医学科学院医学与健康科技创新工程项目(2017-I2M-1-007) 国家重点实验室专项经费(2060204)。
关键词 MRI超短回波时间成像 T2*映射 耳软骨 成分分析 无创评估 MRI ultrashort echo time(UTE) T2*mapping auricular cartilage component analysis noninvasive assessment
  • 相关文献

参考文献3

二级参考文献15

  • 1杜佳梅,庄洪兴,蒋海越,潘博,郭万厚,李学川.先天性小耳畸形患者及其家属心理状况调查研究[J].中华整形外科杂志,2005,21(3):218-221. 被引量:43
  • 2陈佳鹏,张蕾,陈功,宋新明,郑晓瑛.中国1993-1998年出生缺陷监测能力分析[J].中华流行病学杂志,2006,27(5):392-395. 被引量:65
  • 3Howse JL,Howson CP,Katz M.Reducing the global toll of birth defects.Lancet,2005,365:1846-1847.
  • 4WHO.Primary health care approaches for prevention and control of congenital and genetic Disorders.Report of a WHO Meeting,Cairo,Egypt,6-8 December,1999.WHO/HGN/WG/00.1.2000.4.
  • 5WHO/ICBDMS/EUROCAT/HGP.World Atlas of Birth Defects (2nd Edition).Geneva,Switzerland.ISBN 92 4 158029 1.2003.
  • 6Trust for America's Health (TFAH).Birth Defects Tracking and Prevention:Too Many States Are Not Making the Grade.2002.http://healthyamericans.org/reports/tfah/
  • 7Hobbs AC,Hopkins S,Simmons CJ.Sources of variability in birth defects prevalence Rates.Teratology,2001,64:8-13.
  • 8WHO.Prevention and management of genetic disorders and birth defects in developing countries.Report of a joint WHO/WAOPBD meeting.The Hague,1999.25.
  • 9Dolk H.Epidemiological evidence regarding environmental causes of congenital anomalies:interpretational issues.In:EUROCAT Special Report.The environmental causes of congenital anomalies:a review of the literature,2004.30-47.
  • 10Villasen AC,Cragan J,Kucik J,et al.The metropolitan Atlanta congenital defects program:35 years of birth defects surveillance at the centers for disease control and prevention.Birth Defects Research (Part A),2003,67:617-624.

共引文献68

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部